Exelixis
Trade Exelixis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About EXEL
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
EXEL Key Statistics
Stock Snapshot
The current Exelixis(EXEL) stock price is $46.19, with a market capitalization of 12.38B. The stock trades at a price-to-earnings (P/E) ratio of 18.39.
During the trading session on 2026-01-08, Exelixis(EXEL) shares reached a daily high of $46.30 and a low of $43.68. At a current price of $46.19, the stock is +5.8% higher than the low and still -0.2% under the high.
Trading activity shows a volume of 2.5M, compared to an average daily volume of 2.14M.
Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $49.62 and a low of $31.90.
Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $49.62 and a low of $31.90.
EXEL News
Exelixis (EXEL) and Natera (NTRA) announced their collaboration on the planned Exelixis-sponsored STELLAR-316 trial. This randomized phase 3 pivotal trial will...
Exelixis recently announced that President and CEO Michael M. Morrissey, Ph.D., had provided a corporate overview at the J.P. Morgan 2026 Healthcare Conference,...
BofA downgraded Exelixis (EXEL) to Underperform from Neutral with a price target of $41, down from $43, citing valuation and limited high-impact catalysts seen...